Global Medical Director – Rare Liver Disease | Ipsen (Consultancy) | AI/RLHF medical content evaluation, ranking, correction, and red-teaming
Provided medical domain expertise to evaluate and improve AI-generated medical content for RLHF and AI model training, emphasizing clinical accuracy, safety, and guideline compliance. Performed critical review and response correction workflows by identifying hallucinations, logical gaps, and inconsistencies in scientific and clinical outputs. Designed and evaluated prompt and response quality using structured medical evaluation rubrics to support model training objectives. • Conducted clinical accuracy reviews across rare liver disease and broader medical domains. • Performed response correction and scientifically nuanced rewriting of incorrect or incomplete AI outputs. • Applied red-teaming/adversarial testing approaches using complex clinical scenarios and edge-case queries. • Reviewed compliance with EMA, MHRA, NICE, FDA, and promotional/regulatory standards for AI outputs.